Our mission is to triple the pancreatic cancer survival rate by 2030 and dramatically improve the quality of life for those impacted by the disease.
PanKind, The Australian Pancreatic Cancer Foundation, is exclusively dedicated to improving outcomes for Australians impacted by pancreatic cancer.
We are achieving results through a strategic investment in groundbreaking medical research and critically, PanKind is often the first to provide funding for these projects. We are the lead funder, identifying the potential for patients and providing the initial investment to enable projects to grow bigger and have a greater impact.
Early-stage pancreatic cancer rarely causes signs or symptoms, which can make it difficult to diagnose, that is why we are working towards a breakthrough in early detection. We also support patients and carers through information and resources, and advocating for better patient outcomes.
We know from work in other cancers that medical research is the single most important factor impacting patient survival. Due to extensive funding, more high-profile cancers now have 5-year survival rates above 90%. It’s time to make the same improvements for pancreatic cancer.
We invite you to join us on the journey to improve survival rates and the quality of life for the thousands of Australians affected by this disease every year.
Take Action Our Approach
Achievements
Latest news

Putting in the steps for pancreatic cancer in 2023!
In 2023, Shae will be travelling across Australia to participate in every single #PutYourFootDown event! That’s over 12062 kms travelled starting on March 26th and ending on November 5th. It’s a huge undertaking, but for Shae, it’s the least she can do to help spread awareness for pancreatic cancer, a cause that is now very close to her heart.
Read story ➞2023 Woolies Wheels and Walks Launch
PanKind - 2022 Year in Numbers
In Conversation with Eric Idle
Your support matters. Keep in Touch.
Sign up to keep up-to-date with the latest news, upcoming events, personal stories and exciting breakthroughs, sent to your email.